Table 3 Recommendations to facilitate molecular test uptake
Concern raised during interview | Recommendation |
|---|---|
Unfamiliarity with molecular diagnostics | Publicise the technology’s purpose and benefits, particularly its rapidity, accuracy, and ability to facilitate targeted antimicrobial therapy |
Identify and address any misconceptions held by clinicians | |
Establish a trial period for clinician first-hand familiarisation | |
Withholding antibiotics until receiving molecular diagnostic results | Emphasise that empiric antibiotics can be started and refined after molecular diagnostic results become available |